Drug Profile
DWP 418
Alternative Names: DWP-418Latest Information Update: 22 Jan 2015
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antineoplastics; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Head and neck cancer; Malignant melanoma; Solid tumours
Most Recent Events
- 22 Jan 2015 No development reported - Phase-I for Head and neck cancer in South Korea (Intratumoural)
- 22 Jan 2015 No development reported - Phase-I for Malignant melanoma in South Korea (Intratumoural)
- 22 Jan 2015 No development reported - Phase-I for Solid tumours in South Korea (Intratumoural)